Effect of Sharpunkhadi Granules in Childhood Sickle Cell Disease

A RANDOMIZED CONTROLLED CLINICAL STUDY ON SHARPUNKHADI GRANULES IN CHILDHOOD SICKLE CELL DISEASE

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052463

Enrollment

Registered

2023-05-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D758- Other specified diseases of bloodand blood-forming organs

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Pre diagnosed cases will be taken only with positive sickling report 2 Age between 3 years to 16 years irrespective of gender caste religion 3 Patients with sign and symptoms of sickle cell disease 4 Hb >6.5 gm% and 5 Hb electrophoresis reporting % of Hb S >10 gm% 6 Serum Bilirubin less than 3.0 mg/dL

Exclusion criteria

Exclusion criteria: 1 Age less than 3 years and greater than 16 years 2 Patients with known case of hepatic and renal dysfunction and chronic cardiac dysfunction 3 SCA associated with other known diseases like Diabetes Mellitus Hypertension Thalassemia 4 Hb 11.5 gm % 5 Serum bilirubin level more than 3.0mg/dL 6 Known case of other haemoglobinopathies and haematological diseases other than sickle cell anaemia G6PD thalassemia sickle cell beta thalassemia

Design outcomes

Primary

Measure	Time frame
Improvement in Blood indices including Hb% MCV MCHTimepoint: 30 and 60 days	—

Secondary

Measure	Time frame
Improvement in WHO QoL of sickle childrenTimepoint: 30 and 60 days	—

Countries

India

Contacts

Public ContactDr Jaidev Gehija

Parul Institute of Ayurved

neonatecare22@gmail.com9879340491

Outcome results